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Background: Glucagon-like peptide-1 (GLP-1) is a key player in
energy balance, mostly attributed to its glucose-dependent insu-
lin release stimulation ability and food intake regulation. Glu-
cose homeostasis plays a pivotal role in male reproduction,
particularly due to the metabolic cooperation established
between Sertoli cells (SCs) and germ cells. We hypothesize that
GLP-1 participates in spermatogenesis regulation by altering
SCs metabolism.
Materials and methods: GLP-1 receptor was identified in
human SCs by qPCR. Primary human SCs cultures were unex-
posed or exposed to increasing concentrations of GLP-1 (10,
1000 and 100,000 pM) for 6 h. Extracellular media was analysed
by 1H-NMR to determinate metabolites concentration. Protein
levels of glucose transporters, phosphofructokinase, lactate
dehydrogenase (LDH) and monocarboxylate transporter 4 were
determined by Western Blot. To evaluate oxidative damages,
lipid peroxidation, protein carbonylation and nitration were
determined. LDH activity was evaluated by a commercial kit
assay, and mitochondria membrane potential was assessed
using JC-1 dye.
Results: Human SCs were shown to express the GLP-1 recep-
tor. Cells treated with 1000 pM of GLP-1 presented a decrease
in glucose consumption and an increased production of acetate.
Moreover, human SCs treated with all GLP-1 concentrations
dose-dependently increased lactate production. Protein carbony-
lation was decreased in human SCs treated with 1000 pM.
Finally, mitochondria potential membrane was decreased only
in cells exposed to 100,000 pM.
Conclusions: This is the first report showing that GLP-1 can
alter the metabolic support of spermatogenesis by human
SCs, by dose-dependently increasing lactate production which
has been highlighted as crucial to improve the male
reproductive potential. Further studies will be needed to unveil
the possible physiological role of GLP-1 in male reproductive
function.
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Background: High blood pressure is a major risk factor for car-
diovascular disease and premature death. To better understand
the epigenetics of blood pressure, we intend to assess to which
extent regulatory elements influence 69 blood pressure-asso-
ciated variants in different cell types.
Materials and methods: We tested the phenotypic cell-type
specificity of these 69 single nucleotide polymorphisms (SNPs)
and vicinity (r2 > 08) with H3K27ac peaks across 24 datasets
of different tissues. Statistical significance was evaluated by per-
muting 10,000 matched sets of SNPs not associated with the phe-
notype to calculate a 95th-percentile threshold as cell type
specificity score.
Results: The most significant enrichment was in left ventricle,
adrenal gland and right atrium tissues. We found 6 SNPs
mapped to tissue-specific H3K27ac peaks in left ventricle, with
specificity of 063 or greater. These variants (related to genes
NPPA, RP11-103J8.1, PLEKHA7, NPR3 and PLCE1) are in link-
age disequilibrium (LD) with a SNP close to cell-type specific
H3K27ac summit peak (median 1675 bp away). Seven variants
(that relate to genes ADK, PLEKHA7, HECTD4, NPR3, ULK4
and AGT) were above the specificity threshold for adrenal
gland (024), in LD with a marker with median distance of
473 bp from a summit. Finally, 7 SNPs (genes AC092684.1,
RP11-89B16.2, AKAP13, MECOM, ATXN2, FBN1 and PDE1A)
showed significant phenotypic cell-type specificity (060) for
right atrium, with median distance of 84 bp from a chromatin
peak summit.
Conclusions: These preliminary results point to an enrichment
of blood pressure-related SNPs with regulatory regions high-
lighted by H3K27ac peaks. Further analyses may help clarify
the mechanisms through which these SNPs affect genes, iden-
tify the causal variants and their influence in regulatory
regions.
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proteins was determined by Western blot analysis and RT-PCR.
For inhibition of Erk-1/2 MAP kinase was used selective inhibi-
tor PD98059.
Results: The results showed that the redox-sensitive transcrip-
tion factors Egr-1 and Sp-1 enter into competitive interactions
in the early stages of stress and aspirin-induced gastric lesions
in rats. Experimental ulcers caused multidirectional changes in
the level of protein VEGF and bFGF. Development of erosive
and ulcerative lesions in the stomach during stress action was
accompanied by a decrease in the partial pressure of oxygen
in the cells of the gastric mucous membrane, and caused increas-
ing in the level of HIF-1a and reducing protein SH-groups. In
the early stages of stress-induced gastric lesions increased con-
centrations of the stress hormone cortisol in serum is associated
with activation of Erk1/2 MAP-kinase pathway and does not
affect p38. Inhibition of Erk1/2 by the selective inhibitor
PD98059 lead to more aggressive lesions of the stomach accom-
panied by a reduction in Egr-1, and accordingly, pro-angiogenic
factors VEGF and bFGF.
Conclusions: So redox sensitive transcription factor Egr-1 is a
leading transcription factors in the pathogenesis of stress- and
aspirin-induced gastric lesions, unlike ethanol-induced ulcers.
This factor is activated by hypoxia and launches gastroprotec-
tive mechanisms through Erk1/2-dependent mechanism.
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Background: Rett syndrome (RTT) is a severe neurological dis-
order that affects almost exclusively females. This disease is
characterized by normal growth and intellectual development
until around the first year, then progression in development
starts to slow down, with loss of purposeful use of the hands,
distinctive hand movements, slowed brain and head growth,
problems with walking, seizures, and intellectual disability.
Mutations in the X-linked genes methyl-CpG-binding protein 2
(MECP2) and cyclin-dependent kinase-like 5 (CDKL5) were
described in RTT and recently several bone diseases related with
decreased bone mass were also described in those patients, start-
ing early in life. Because zebrafish was largely validated as a
model for human diseases, the main objective of this work
was to investigate if zebrafish can be a good model to study RTT.
Materials and methods: For this purpose, we initiated studies
comparing zebrafish and human MECP2 and CDKL5 regarding
their chromosomal environment, gene structure, promoter regu-
lation and protein conservation.
Results: In silico analysis showed that both human genes are
localized in chromosome X In zebrafish, mecp2 and cdkl5 are
located in chromosome 8 and 11, respectively and their flanking
genes are conserved between species. Both genes share the same
genetic structure as their humanorthologsandboth speciespresent
alternatively spliced isoforms for both genes. Zebrafish andhuman
MECP2 and CDKL5 promoter regions present similar putative
binding sites for known transcriptional factors. Bioinformatic anal-
ysis of corresponding protein showed a high degree of conserva-
tion in both three dimensional structures and functional domains.
Conclusion: In conclusion, this study demonstrates that
zebrafish has the appropriate genetic characteristics to be further
considered as model to investigate bone diseases associated with
RTT.
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Background: Optineurin (OPTN) is a gene located in chromo-
some 10 that has been associated with several pathologies,
including Paget’s disease of bone (PDB). Using DNA samples
from our cohort of PDB patients we have found two SNPs in
OPTN promoter (rs3829923 and RV -9906) that could alter OPTN
expression. However little is known about the role of this gene
in bone and how this gene is regulated.
Materials and methods: Using bioinformatics, we analyzed the
OPTN promoter to look for NFkB putative binding sites and per-
formed several deletion constructs to identify the most impor-
tant regulatory region within the OPTN promoter. By
transfection and co-transfection assays, we analyzed the activity
of each construct in the presence of NFkB. Moreover, we also
assessed the effect in the promoter activity of the variants iden-
tified for rs3829923 and RV -9906.
Results: Our results showed that rs3829923 T allele increases
OPTN promoter activity due to a gain of E47 and E2F1 inductive
effect, and the rare variant RV -9906 was responsible for an
increase of OPTN promoter activity due to a loss of SP1 inhibi-
tory effect. Our results also showed that NFkB and E2F3 regulate
positively and that RXR regulates negatively OPTN promoter
activity.
Conclusions: Our work clarified the functional effect of these
variants found in OPTN gene of PDB patients and how these
variants could contribute to PDB pathophysiology. Also with
this work we were able to define genomic regions important
for NFkB, E47, SP1 and E2F1 regulatory effects, unraveling
new OPTN regulators.
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